Evidence map›Paper›PMID 23929898›Full record

ArticleCirculation. Cardiovascular imaging2013

Relation of regional fat distribution to left ventricular structure and function.

Ian J Neeland, Sachin Gupta, Colby R Ayers, Aslan T Turer, J Eduardo Rame, Sandeep R Das, Jarett D Berry, Amit Khera, Darren K McGuire, Gloria L Vega and 3 more

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Circulation. Cardiovascular imaging, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03038620 (Impact of Liraglutide 3.0 on Body Fat Distribution, Visceral Adiposity, and Cardiometabolic Risk Markers In Overweight and Obese Adults at High Risk for Cardiovascular Disease), which is not on this map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03038620 phase4completedstarted 2017, after this paper: background citation

Impact of Liraglutide 3.0 on Body Fat Distribution, Visceral Adiposity, and Cardiometabolic Risk Markers In Overweight and Obese Adults at High Risk for Cardiovascular Disease

Ran2017Enrolled235Registered outcomes37Posted comparisons0ConditionsCardiovascular Diseases, Fat Disorder, Obesity, VisceralArmsliraglutide, Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Ian J NeelandDivision of Cardiology, Department of Internal Medicine, Department of Clinical Sciences, and Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas; and Cardiovascular Research Institute, University of Pennsylvania, Philadelphia.
Sachin Gupta
Colby R Ayers
Aslan T Turer
J Eduardo Rame
Sandeep R Das
Jarett D Berry
Amit Khera
Darren K McGuire
Gloria L Vega
Scott M Grundy
James A de Lemos
Mark H Drazner
University City Science Center · US

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
TRAINING IN CARDIOVASCULAR RESEARCHT32HL007360 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HILL, JOSEPH A · 1985 to 2012
$11.8M
UT-Southwestern Clinical and Translational Alliance for Research (UT-STAR) (TL1)UL1TR000451 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2012 to 2012
$6.3M
Mouse Phenotype Core, Project 9 of 10PL1DK081182 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI RUSSELL, DAVID W. · 2007 to 2011
$2.0M
Taskforce for Obesity Research at Southwestern (TORS)UL1DE019584 · NIDCR · UT SOUTHWESTERN MEDICAL CENTER · PI HORTON, JAY D. · 2008 to 2011
$1.5M
NCATS NIH HHS UL1 TR000451NCATS NIH HHS UL1TR000451NCATS NIH HHS UL1 TR001105NHLBI NIH HHS T32 HL007360NHLBI NIH HHS T32HL007360NIDCR NIH HHS UL1 DE019584NIDCR NIH HHS UL1DE019584NIDDK NIH HHS PL1 DK081182NIDDK NIH HHS PL1DK081182
6 · The paper itself

Abstract

backgroundThe relation of body fat distribution to left ventricular (LV) structure and function is poorly defined. METHODS AND

resultsA total of 2710 participants without heart failure or LV dysfunction in the Dallas Heart Study underwent dual energy x-ray absorptiometry and MRI assessment of fat distribution, LV morphology, and hemodynamics. Cross-sectional associations of fat distribution with LV structure and function were examined after adjustment for age, sex, race, comorbidities, and lean mass. Mean age was 44 years with 55% women; 48% blacks; and 44% obese. After multivariable adjustment, visceral adipose tissue was associated with concentric remodeling characterized by lower LV end-diastolic volume (β=-0.21), higher concentricity (β=0.20), and wall thickness (β=0.09; P<0.0001 for all). In contrast, lower body subcutaneous fat was associated with higher LV end-diastolic volume (β=0.48), reduced concentricity (β=-0.50), and wall thickness (β=-0.28, P<0.0001 for all). Visceral adipose tissue was also associated with lower cardiac output (β=-0.10, P<0.05) and higher systemic vascular resistance (β=0.08, P<0.05), whereas lower body subcutaneous fat associated with higher cardiac output (β=0.20, P<0.0001) and lower systemic vascular resistance (β=-0.18, P<0.0001). Abdominal subcutaneous fat showed weaker associations with concentric remodeling and was not associated with hemodynamics. Among the subset of obese participants, visceral adipose tissue, but not abdominal subcutaneous fat, was significantly associated with concentric remodeling.

conclusionsVisceral adipose tissue, a marker of central adiposity, was independently associated with concentric LV remodeling and adverse hemodynamics. In contrast, lower body subcutaneous fat was associated with eccentric remodeling. The impact of body fat distribution on heart failure risk requires prospective study.

Indexed as

AdiposityHemodynamicsVentricular Function, LeftVentricular RemodelingAbsorptiometry, PhotonAdultCardiac OutputChi-Square DistributionCross-Sectional StudiesFemaleHumansHypertrophy, Left VentricularIntra-Abdominal FatLinear ModelsLogistic ModelsMagnetic Resonance Imagingbody fat distributionconcentric remodelinghypertrophy, left ventricularintra-abdominal fatobesity

Identifiers

PMID23929898
PMCPMC3931513
OpenAlexW2156271459

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.